PMA device
INFUSAID Implantable Infusion Pump and Accessories
Intera Oncology · Pump, Infusion, Implanted, Programmable (LKK, Class III) · First FDA decision Jun 23, 2006, newest Feb 7, 2020Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "INFUSAID"
MAUDE reports
0
Brand "INFUSAID", since 2015
PubMed studies
114
Mentioning "INFUSAID"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing INFUSAID Implantable Infusion Pump and Accessories
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- INFUSAID Implantable Infusion Pump and AccessoriesPMA supplement
P800036-S041 · Decided Feb 7, 2020 · 29 days after receipt · Normal 180 Day Track No User Fee
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
- INFUSAID MODEL 400 IMPLANTABLE INFUSION PUMPPMA supplement
P800036-S038 · Decided Aug 1, 2014 · 35 days after receipt · Normal 180 Day Track No User Fee
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
- INFUSAID MODEL 400 IMPLANTABLE INFUSION PUMPPMA supplement
P800036-S036 · Decided Jun 23, 2006 · 63 days after receipt · Normal 180 Day Track No User Fee
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "INFUSAID", any status and sponsor, newest update first.
No registered device study names "INFUSAID".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "INFUSAID", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LKK
71,356 reports: 25,333 malfunction, 45,674 injury, 326 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "INFUSAID"[tiab]. The summary above synthesizes these.
- Implantable pumps.
Sefton MV · Crit Rev Biomed Eng · 1987Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- Shiley INFUSAID Pump technology.
Johnston J, Reich S, Bailey A, et al. · Ann N Y Acad Sci · 1988
- Instability of vancomycin in Infusaid drug pump model 100.
Greenberg RN, Saeed AM, Kennedy DJ, et al. · Antimicrob Agents Chemother · 1987
- DSA evaluation of surgically implantable infusaid pump-catheter systems.
Sanchez FW, Chuang VP, Murray DR, et al. · AJR Am J Roentgenol · 1986Case Reports
- The Infusaid pump in the management of intractable cancer pain.
Bryant DD, DeWitty RL, Dennis GC · J Natl Med Assoc · 1987Case Reports
- Regional chemotherapy of neoplastic diseases.
Ensminger WD, Gyves JW · Pharmacol Ther · 1983Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- The implantable "Infusaid" infusion pump. The Sydney experience using 5-fluorouracil.
Stephens FO, Crea P, Walker PJ · Med J Aust · 1986Comparative Study
- Implanted pump systems for treatment of spasticity.
Zierski J, Müller H, Dralle D, et al. · Acta Neurochir Suppl (Wien) · 1988
- Chronic intrathecal morphine for intractable pain.
Penn RD, Paice JA · J Neurosurg · 1987
- Hepatic artery infusion chemotherapy with the Infusaid pump: a Canadian experience.
Winton TL, Ghent WR · Can J Surg · 1986
- Totally implanted venous and arterial access system to replace external catheters in cancer treatment.
Niederhuber JE, Ensminger W, Gyves JW, et al. · Surgery · 1982Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- [Perfusion of the peridural, peri- and subarachnoid spaces: our experience with Infusaid and Mocavero capsules].
Mocavero G, Rinaldi A, Campailla A, et al. · Minerva Anestesiol · 1984Comparative Study, English Abstract
Other devices of this type
Also filed under product code LKK.
- SynchroMed Infusion System, Ascenda Intrathecal CathetersMedtronic, Inc. · PMA 2026
- Prometra Programmable Infusion Pump SystemInfusyn Therapeutics, LLC · PMA 2025
- Synchromed II Pump RemediationMedtronic, Inc. · PMA 2017
- Implantable System for RemodulinMedtronic, Inc. · PMA 2021
- Medstream Programmable Infusion SystemIntera Oncology · PMA 2014
- IsoMed Infusion SystemMedtronic, Inc. · PMA 2023
- Medtronic(R) Synchromed(Tm) Pump & Infusion SystemMedtronic, Inc. · PMA 2018
- 3000 Series Implantable Infusion Pump and the MedStream Programmable Infusion System and AccessoriesIntera Oncology · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.